歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁 > 小分子抑制劑 > CellCycle/Checkpoint > LMI070

瀏覽歷史

S83593

LMI070

源葉(MedMol) 98%
  • 英文名:
  • LMI070
  • 別名:
  • 5-(1H-pyrazol-4-yl)-2-(6-((2,2,6,6-tetramethylpiperidin-4-yl)oxy)pyridazin-3-yl)phenol
  • CAS號(hào):
  • 1562338-42-4
  • 分子式:
  • C22H27N5O2
  • 分子量:
  • 393.4821
  • 核磁/質(zhì)譜:
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購物車...
源葉(MedMol) S83593-2mg 98% ¥523.60元 4 - - - EA 加入購物車
源葉(MedMol) S83593-5mg 98% ¥640.00元 4 - - - EA 加入購物車
源葉(MedMol) S83593-10mg 98% ¥880.00元 5 - - - EA 加入購物車
源葉(MedMol) S83593-25mg 98% ¥1900.00元 5 - - - EA 加入購物車
源葉(MedMol) S83593-50mg 98% ¥3200.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購物車
源葉(MedMol) S83593-100mg 98% ¥5500.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購物車
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說明書。
  • 產(chǎn)品描述: Branaplam (LMI070; NVS-SM1) is a highly potent, selective and orally active survival motor neuron-2 (SMN2) splicing modulator with an EC50 of 20 nM for SMN. Branaplam inhibits human-ether-a-go-go-related gene (hERG) with an IC50 of 6.3 μM. Branaplam elevates full-length SMN protein and extends survival in a severe spinal muscular atrophy (SMA) mouse model
  • 靶點(diǎn): IC50: 20 nM (SMN) EC50: 6.3 μM (hERG);thers;?PotassiumChannel;?DNA/RNASynthesis
  • 體外研究:
    Branaplam (LMI070; NVS-SM1) treatment induces changes in the levels of 175 genes in human fibroblasts
  • 體內(nèi)研究:
    Branaplam (LMI070; NVS-SM1; 3, 10, 30 mg/kg; oral) produces dose-dependent elevations of SMN2-FL transcript and SMN protein in brain and spinal cord. Branaplam (1 mg/kg of IV; 3 mg/kg of PO) has a CL of 25 mL/min/kg and an AUC of 3.03 μM?h.A single Branaplam (oral; 30 mg/kg) results in significant and durable SMN protein elevation in brain for up to 160 hours in C/+ mice. Branaplam (oral; 0.03, 0.1, 0.3, 1, 3 mg/kg) improves body weight and extendes lifespan in n SMNΔ7 mice. Animal Model: C/+ SMA mouse model Dosage: 3, 10, 30 mg/kg Administration: Oral Result: Produced dose-dependent elevations of SMN2-FL transcript and SMN protein in brain and spinal cord. Animal Model: Male Sprague-Dawley rat Dosage: 1 mg/kg (IV);3 mg/kg (PO) (Pharmacokinetic Analysis) Administration: IV or PO Result: Had a CL of 25 mL/min/kg and an AUC of 3.03 μM?h.
  • 參考文獻(xiàn):
    1. Palacino J, et al. SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nat Chem Biol. 2015 Jul;11(7):511-517. 2. Cheung AK, et al. Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA). J Med Chem. 2018 Dec 27;61(24):11021-11036.
  • 溶解性: Soluble  in  DMSO
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.541 ml 12.707 ml 25.414 ml
    5 mM 0.508 ml 2.541 ml 5.083 ml
    10 mM 0.254 ml 1.271 ml 2.541 ml
    50 mM 0.051 ml 0.254 ml 0.508 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。